concept

TAU HYPERPHOSPHORYLATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TAU HYPERPHOSPHORYLATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

64Connections
0Hypotheses
3Analyses
16Outgoing
48Incoming
0Experiments
4Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameTAU HYPERPHOSPHORYLATION

Pathway Diagram

graph TD
    TAU_HYPERPHOSPHORYLATION["TAU HYPERPHOSPHORYLATION"]
    TAU_HYPERPHOSPHORYLATION -->|"contributes to"| Tau_Aggregation["Tau Aggregation"]
    TAU_HYPERPHOSPHORYLATION -->|"causes"| Alzheimer_s_disease["Alzheimer's disease"]
    MAPT["MAPT"] -->|"involved_in"| TAU_HYPERPHOSPHORYLATION
    Exendin_4["Exendin-4"] -->|"inhibits"| TAU_HYPERPHOSPHORYLATION
    ASK1["ASK1"] -->|"causes"| TAU_HYPERPHOSPHORYLATION
    Wnt___catenin_NeuroD1_Pathway["Wnt/beta-catenin/NeuroD1 Pathway"] -->|"regulates"| TAU_HYPERPHOSPHORYLATION
    Neuroinflammation["Neuroinflammation"] -->|"contributes to"| TAU_HYPERPHOSPHORYLATION
    HEPATOKINES["HEPATOKINES"] -->|"regulates"| TAU_HYPERPHOSPHORYLATION

Outgoing (16)

TargetRelationTypeStr
Alzheimer's Diseaseassociated_withdisease0.95
Neurofibrillary Tanglescausesbiomarker0.95
Cognitive Impairmentsassociated_withphenotype0.90
Alzheimer'S Diseasebiomarker_fordisease0.90
Tauopathiesbiomarker_fordisease0.90

Incoming (48)

SourceRelationTypeStr
MAPTinvolved_inprotein0.95
PPP2CAregulatesgene0.95
GSK3Binvolved_ingene0.95
DABcausescompound0.95
PKRcausesentity0.90

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (3)

Scientific analyses that reference this entity

Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determ

neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.585

Clinical Trial Landscaping for Alzheimer's Disease Therapeutics

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.629

Does tau aggregation specifically cause PS externalization in vesicles independe

neurodegeneration | 2026-04-11 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (4)

Multi-agent debates referencing this entity

Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determ

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

The debate revealed a fundamental gap in understanding whether tau pathology dir

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

What is the current clinical trial landscape for AD therapeutics, and which mech

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

Is the amyloid concentration in AD clinical trials rational given lecanemab's ap

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Related Research

Hypotheses and analyses mentioning TAU HYPERPHOSPHORYLATION in their description or question text

No additional research found